DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b6f1a8/global_metabolic_s) has announced the addition of the "Global Metabolic Syndrome Drug Pipeline Capsule - 2011" report to their offering.
Fore Pharma's latest report Global Metabolic Syndrome Drug Pipeline Capsule - 2011' is an outline of all the key research and development (R&D) activities of the global metabolic syndrome drug market. It covers information on key pipeline molecules in various stages of R&D including all the phases of clinical trials, preclinical research, and drug discovery.
This report helps executives to keep a track of their competitors and understand their pipeline molecules. The information presented in this report can be used for identifying the partners, prioritizing, evaluating opportunities, developing business development strategies, and executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the different stages of R&D. It includes registered / preregistered stage, phase 3 clinical trial, phase 2 clinical trial, phase 1 clinical trial, preclinical research, and drug discovery. It also provides information on pipeline molecules developed in leading geographies including the U.S., Canada, France, Germany, U.K., Italy, and Spain by various stages of R&D. Licensing activities and partnerships in the metabolic syndrome drug market is thoroughly covered by company and licensee with the deal summary.
The key topics covered by "Global Metabolic Syndrome Drug Pipeline Capsule - 2011" include:
- Metabolic Syndrome: Overview
- Metabolic Syndrome Drug Pipeline Overview
- Metabolic Syndrome Phase 3 Clinical Trial Drug Pipeline Insights
- Metabolic Syndrome Phase 2 Clinical Trial Drug Pipeline Insights
- Metabolic Syndrome Phase 1 Clinical Trial Drug Pipeline Insights
- Metabolic Syndrome Preclinical Research Drug Pipeline Insights
- Metabolic Syndrome Drug Discovery Pipeline Insights
- Geographic Landscape of Metabolic Syndrome R&D Activities
- Metabolic Syndrome R&D Activities in North America
- Metabolic Syndrome R&D Activities in Europe
- Licensing Activities / Partnerships in the Global Metabolic Syndrome Drug Market
For more information visit http://www.researchandmarkets.com/research/b6f1a8/global_metabolic_s